Attachment A NTX Specialty Reference Lab CPT.xlsx
XLSX spreadsheet 18 KB Posted
- Attached to
- Q301--Reference Laboratory Testing Service (NTX) Federal contract opportunity
- Solicitation number
- 36C25721Q0579
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 36C25721Q0579 0001_1.docx | DOCX document | |
| Amendment 36C25721Q0579 0001.pdf | ||
| 36C25721Q0579.pdf | ||
| 36C25721Q0579_1.docx | DOCX document | |
| WD 15-5227.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Item Number | Test Name | CPT Codes | Estimated Annual Test Volume | Unit Price | |
| Pricing Period 1 | Uinit Price | ||||
| Pricing Period 2 | Unit Price | ||||
| Pricing Period 3 | Uinit Price | ||||
| Pricing Period 4 | Unit Price | ||||
| Pricing Period 5 | Unit Price | ||||
| Option 1 | Turnaround Time (TAT) | Lab Performing Test | CLIA Number of Lab Performing Test | Location of Lab Performing Test | |
| 1 | Adalimumab Quantitative with Reflex to Antibody, Serum | 80299 | 33 | ||
| 2 | Additional Identification Procedure (Bill Only) | 87077 | 4 | ||
| 3 | Adenosine Deaminase, CSF | 84311 | 2 | ||
| 4 | Alpha-Galactosidase, Serum | 82657 | 3 | ||
| 5 | Alpha-Globin Gene Analysis | 81269 | 8 | ||
| 6 | Alpha-Subunit Pituitary Tumor Marker, Serum | 82397 | 1 | ||
| 7 | Amino Acids, Urea Cycle Disorders Panel, Plasma | 82136 | 3 | ||
| 8 | Amyloid Protein Identification, Paraffin, LC-MS/MS | 88313 | 1 | ||
| 9 | Arbovirus Antibody Panel, IgG and IgM, Spinal Fluid | 86651 x2, 86652 x2, 86653 x2, 86654 x2 | 1 | ||
| 10 | Aspergillus Antigen, Bronchoalveolar Lavage | 87305 | 25 | ||
| 11 | Autoimmune Dysautonomia Evaluation, Serum | 83519 x5, 83520, 86255 x2, 86341 | 2 | ||
| 12 | BCR/ABL, p190, Quant, Monitor | 81207 | 22 | ||
| 13 | BCR/ABL1 MUTATION, SEQUENCING | 81170 | 5 | ||
| 14 | BCR/ABL1 REFLEX, QUAL/QUANT | 81206, 81207, 81208 | 4 | ||
| 15 | Beta-2 Transferrin: Detection of Spinal Fluid in Other Body Fluid | 86335 | 1 | ||
| 16 | BK Virus, Molecular Detection, Quantitative, PCR, Plasma | 87799 | 13 | ||
| 17 | CEBPA Mutations, Gene Sequencing | 81218-CEBPA | 1 | ||
| 18 | Certolizumab Quant | 80299, 82397 | 7 | ||
| 19 | Chromogranin A, Serum | 86316 | 150 | ||
| 20 | CMV, DNA, Qualitative PCR | 87496 | 10 | ||
| 21 | CNS Demyelinating Disease Evaluation, Serum | 86255 x2 | 1 | ||
| 22 | Complement Mediated AHUS/TMA panel | 81479 | 2 | ||
| 23 | Copper, Liver tissue | 82525 | 1 | ||
| 24 | Encephalitis - Calif (LaCrosse) IgM/IgG | 86651 x2, | 2 | ||
| 25 | Encephalitis - East Equine IgM/IgG | 86652 x2 | 2 | ||
| 26 | Encephalitis - St. Louis IgM/IgG | 86653x2 | 2 | ||
| 27 | Encephalopathy, Autoimmune Evaluation, Serum | 83519 x3, 86255 x19, 86341 | 2 | ||
| 28 | Encephalopathy-Autoimmune Eval, CSF | 86255 (19), 86341 | 7 | ||
| 29 | ERYTHROCYTOSIS EVALUATION | 83020, 83021, 83789, 82820 | 5 | ||
| 30 | Fatty Acid Profile, Essential, Serum | 82542 | 3 | ||
| 31 | Germ Cell Tumor (GCT), Isochromosome 12p, FISH, Tissue | 88271x2, 88291 | 1 | ||
| 32 | FLT3 Mutation Analysis, Varies | 81245-FLT3 | 2 | ||
| 33 | Fungitell, Bronchoalveolar lavage | 87449 | 5 | ||
| 34 | Fungitell, Serum | 87449 | 132 | ||
| 35 | Fructose, Semen | 82757 | 33 | ||
| 36 | Helicobacter pylori Culture with Antimicrobial Susceptibilities | 87081, 87077, 87153, 87176, 87181,87186, 87150 | 5 | ||
| 37 | Hemochromatosis HFE Gene Analysis, Blood | 81256 | 91 | ||
| 38 | HIV-1 DNA/RNA | 87535 | 6 | ||
| 39 | HLA-B*57:01 Genotype, Pharmacogenomics | 81381 | 5 | ||
| 40 | HLA-B*5801 Genotype, Allopurinol Hypersensitivity | 81381 | 2 | ||
| 41 | Hypoglycemic Agent Screen | 80307 | 1 | ||
| 42 | Ident by MALDI-TOF Mass Spec (Bill Only) | 87077 | 20 | ||
| 43 | IgG Subtypes, Tissue | 88346, 88350 | 2 | ||
| 44 | Inflammatory Bowel Disease Primary Immunodeficiency (PID) Panel | 81443 | 6 | ||
| 45 | Infliximab Quantitation with Reflex to Antibodies to Infliximab, Serum | 80299 | 34 | ||
| 46 | Iron, Liver Tissue | 83540 | 4 | ||
| 47 | Kidney Stone Analysis | 82354 | 110 | ||
| 48 | KIT Mutation Exons 8-11 and 17, Hematologic Neoplasms | 81272-KIT | 1 | ||
| 49 | Lipoprotein Metabolite Profile | 82465, 84478, 82172, 83718, 83700 | 14 | ||
| 50 | Macroprolactin, Serum | 84146 x 2 | 3 | ||
| 51 | Myelin Oligodendrocyte Glycoprotein (MOG-IgG1) Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | 86255 | 7 | ||
| 52 | Myeloproliferative Neoplasm, CALR with Reflex to MPL | 81219-CALR, 81403-MPL | 8 | ||
| 53 | Mycobacterium tuberculosis Complex, Molecular Detection, PCR, | 87556, 87015 | 1 | ||
| 54 | Muscle-Specific Kinase (MuSK) Autoantibody, Serum | 83519 | 5 | ||
| 55 | Myasthenia Gravis (MG)/Lambert-Eaton Syndrome (LES) Evaluation, Serum | 83519 x4, 83520 | 56 | ||
| 56 | Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM), MYD88 L265P with Reflex to CXCR4 | 81305 | 2 | ||
| 57 | Myelin Oligodendrocyte Glycoprotein (MOG-IgG1) Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | 86255 | 20 | ||
| 58 | Myeloproliferative Neoplasm (MPN), CALR with Reflex to MPL, Varies | 81219 | 28 | ||
| 59 | Necrotizing Myopathy Evaluation (HMGCoA and SRP IgG) | 86255, 82397 | 12 | ||
| 60 | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Serum | 86255 | 4 | ||
| 61 | Next Gen Sequencing, AML, 11 Gene | 81450 | 3 | ||
| 62 | Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Fluorescence-Activated Cell Sorting (FACS) Assay, Spinal Fluid | 86255 86256 | 2 | ||
| 63 | Nucleophosmin (NPM1) Mutation Analysis | 81310 | 1 | ||
| 64 | OncoHeme Next-Generation Sequencing for Myeloid Neoplasms | 81450 | 2 | ||
| 65 | Organism Referred for Identification, Aerobic Bacteria | 87077 | 19 | ||
| 66 | Organism Referred for Identification, Anaerobic Bacteria | 87076, 87153, 87077, 87147, 87798 | 5 | ||
| 67 | Ovarian Malignancy Risk (ROMA) | 86306, 86304 | 24 | ||
| 68 | Phenosense Integrase Susceptibility | 550230 | 70 | ||
| 69 | Phospholipase A2 Receptor Antibodies, Serum | 83520, 86522 | 45 | ||
| 70 | PML/RARA Quantitative, PCR | 81315 | 7 | ||
| 71 | Pneumocystis jiroveci, Molecular Detection, PCR | 8779 | 3 | ||
| 72 | Polycythemia Vera, JAK2 V617F with Reflex to JAK2 Exon 12-15, Sequencing for Erythrocytosis, Varies | 81270 | 324 | ||
| 73 | Procollagen I | 83519 | 6 | ||
| 74 | Prometheus Thiopurine Metabolites | 82542 | 25 | ||
| 75 | Pyruvate Kinase, RBC | 84220 | 2 | ||
| 76 | Pyruvate Kinase Liver and Red Blood Cell (PKLR), Full Gene Sequencing and Large Deletion Detection | 81405-PKLR | 2 | ||
| 77 | Culture Referred for Identification, Fungus | 87107, 87106 | 6 | ||
| 78 | Antimicrobial Susceptibility Panel, Yeast | 87186 | 8 | ||
| 79 | RBC Membrane Evaluation | 85551, 88184 | 1 | ||
| 80 | Ribosome P Antibodies, IgG | 83516 | 3 | ||
| 81 | RNP Antibodies, IgG, Serum | 86235 | 4 | ||
| 82 | Schistosoma Exam, Random, Urine | 87210, 87015 | 1 | ||
| 83 | Semen Analysis | 89310 | 118 | ||
| 84 | Sensitivity, MIC (Bill Only) | 87186 | 8 | ||
| 85 | Somatic Gene Mutation, MYD88, L265P, DNA allele-specific PCR | 81305 | 3 | ||
| 86 | Striational (SM) Antibody, Serum | 83520 | 2 | ||
| 87 | Streptococcus pneumoniae Antigen, Urine | 87899 | 94 | ||
| 88 | Sulfonylurea Screen, Urine | 80377 | 6 | ||
| 89 | Tick Borne Antibody Panel | 86618, 86666 x2, 86753 | 3 | ||
| 90 | Trypanosoma cruzi IgG Antibody, Lateral Flow Assay, Serum | 86753 | 2 | ||
| 91 | Ustekinumab Quantitation with Antibodies, Serum | 80299, 83520 | 11 | ||
| 92 | Vedolizumab Quantitation with Antibodies, Serum | 80299, 82397 | 27 | ||
| 93 | Viral Culture, Non-Respiratory | 87252 | 4 | ||
| 94 | VZV DNA, Qual PCR Body fluid | 87798 | 16 |
VA North Texas Health Care System Attachment A NTX Specialty Reference Laboratory Testing CPT
Attachment A 36C25721Q0579
File details come from the government source that posted it. Updated .